Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy

Learn how new breast cancer treatments improve outcomes with personalized, targeted, and immune-based therapies.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

Prostate cancer remains one of the most commonly diagnosed malignancies in men, with a proportion falling into the intermediate-risk category.

Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods

Learn about early breast cancer detection, symptoms, risk factors, and the best screening methods to stay safe.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

Ovarian cancer remains one of the most lethal gynecologic malignancies, with epithelial ovarian carcinomas accounting for the majority of cases.

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025

Explore the latest trends in colorectal cancer, including rising early-onset cases, updated statistics, risk factors, screening guidelines, treatment

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies

Malignant peritoneal neoplasms, encompassing primary tumors like peritoneal mesothelioma and secondary metastatic spread (peritoneal carcinomatosis)

Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response

Tertiary lymphoid structures (TLSs) are ectopic, organized lymphoid aggregates that develop in non-lymphoid tissues under conditions of chronic inflam

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts

Pancreatic diseases, including pancreatitis and pancreatic ductal adenocarcinoma (PDAC), represent a significant global health burden due to their agg

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies

Breast cancer remains one of the most prevalent malignancies worldwide, with therapy resistance posing a significant challenge in achieving long-term

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance

Cancer remains one of the most formidable challenges in modern medicine, with its ability to evade treatment and sustain uncontrolled proliferation.

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer

Colon cancer remains one of the most prevalent and deadly malignancies worldwide, with increasing incidence rates in younger populations.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD).